# Novo Nordisk timeline entity: /record/novo-nordisk.md id: ent_novo-nordisk Novo Nordisk's timeline holds 55 claims from 2010 to 2025: 2 people, 42 money & deals, 11 other. 11 are undated. The latest took effect on December 31, 2025. Kinds: People 2 (/timelines/novo-nordisk.md?kind=people) · Money & deals 42 (/timelines/novo-nordisk.md?kind=money) · Products 0 (/timelines/novo-nordisk.md?kind=products) · Models 0 (/timelines/novo-nordisk.md?kind=models) · Other 11 (/timelines/novo-nordisk.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2010 - 2010-09-23 | other | x_username | novonordisk | unverified | [clm_C639BE305784](/claim/clm_C639BE305784.md) ## 2018 - 2018-12-31 to 2019-12-31 | money | total_equity | 51,839,000,000 DKK | superseded | [clm_3322844F3158](/claim/clm_3322844F3158.md) ## 2019 - 2019-12-31 to 2020-12-31 | money | employees | 43,258 employee | superseded | [clm_277344156E80](/claim/clm_277344156E80.md) - 2019-12-31 to 2020-12-31 | money | net_income | 38,951,000,000 DKK | superseded | [clm_DA4855A5F51A](/claim/clm_DA4855A5F51A.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 52,483,000,000 DKK | superseded | [clm_B2B75C38DC99](/claim/clm_B2B75C38DC99.md) - 2019-12-31 to 2020-12-31 | money | revenue | 122,021,000,000 DKK | superseded | [clm_F0275DE8A21D](/claim/clm_F0275DE8A21D.md) - 2019-12-31 to 2020-12-31 | money | total_equity | 57,593,000,000 DKK | superseded | [clm_43C7BF9EE087](/claim/clm_43C7BF9EE087.md) ## 2020 - 2020-12-31 to 2021-12-31 | money | employees | 45,323 employee | superseded | [clm_5D92621F8B64](/claim/clm_5D92621F8B64.md) - 2020-12-31 to 2021-12-31 | money | net_income | 42,138,000,000 DKK | superseded | [clm_2112055E65B9](/claim/clm_2112055E65B9.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 54,126,000,000 DKK | superseded | [clm_D272A9AE2D76](/claim/clm_D272A9AE2D76.md) - 2020-12-31 to 2021-12-31 | money | revenue | 126,946,000,000 DKK | superseded | [clm_67D64D48F06E](/claim/clm_67D64D48F06E.md) - 2020-12-31 to 2021-12-31 | money | total_assets | 144,922,000,000 DKK | superseded | [clm_072CD0878EE5](/claim/clm_072CD0878EE5.md) - 2020-12-31 to 2021-12-31 | money | total_equity | 63,325,000,000 DKK | superseded | [clm_D44DDD0D515C](/claim/clm_D44DDD0D515C.md) ## 2021 - 2021-12-31 to 2022-12-31 | money | employees | 48,478 employee | superseded | [clm_71916DF751CE](/claim/clm_71916DF751CE.md) - 2021-12-31 to 2022-12-31 | money | net_income | 47,757,000,000 DKK | superseded | [clm_8F5ADB2C07ED](/claim/clm_8F5ADB2C07ED.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 58,644,000,000 DKK | superseded | [clm_4E462623C749](/claim/clm_4E462623C749.md) - 2021-12-31 to 2022-12-31 | money | revenue | 140,800,000,000 DKK | superseded | [clm_DEF63B463032](/claim/clm_DEF63B463032.md) - 2021-12-31 to 2022-12-31 | money | total_assets | 194,508,000,000 DKK | superseded | [clm_6D30A77C658F](/claim/clm_6D30A77C658F.md) - 2021-12-31 to 2022-12-31 | money | total_equity | 70,746,000,000 DKK | superseded | [clm_1B204B243A08](/claim/clm_1B204B243A08.md) ## 2022 - 2022-12-31 to 2023-12-31 | money | employees | 55,185 employee | superseded | [clm_D62CD294DD73](/claim/clm_D62CD294DD73.md) - 2022-12-31 to 2023-12-31 | money | net_income | 55,525,000,000 DKK | superseded | [clm_1A208DF6F487](/claim/clm_1A208DF6F487.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 74,809,000,000 DKK | superseded | [clm_F3418E0D3161](/claim/clm_F3418E0D3161.md) - 2022-12-31 to 2023-12-31 | money | revenue | 176,954,000,000 DKK | superseded | [clm_459BEEC0AB43](/claim/clm_459BEEC0AB43.md) - 2022-12-31 to 2023-12-31 | money | total_assets | 241,257,000,000 DKK | superseded | [clm_56708B41C767](/claim/clm_56708B41C767.md) - 2022-12-31 to 2023-12-31 | money | total_equity | 83,486,000,000 DKK | superseded | [clm_800F88E2D840](/claim/clm_800F88E2D840.md) ## 2023 - 2023-12-31 to 2024-12-31 | money | employees | 64,319 employee | superseded | [clm_5B1E4C20C74E](/claim/clm_5B1E4C20C74E.md) - 2023-12-31 to 2024-12-31 | money | net_income | 83,683,000,000 DKK | superseded | [clm_A49F4F076521](/claim/clm_A49F4F076521.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 102,574,000,000 DKK | superseded | [clm_792EA3966BEF](/claim/clm_792EA3966BEF.md) - 2023-12-31 to 2024-12-31 | money | revenue | 232,261,000,000 DKK | superseded | [clm_8ED842A2DCE7](/claim/clm_8ED842A2DCE7.md) - 2023-12-31 to 2024-12-31 | money | total_assets | 314,486,000,000 DKK | superseded | [clm_A36685A1C540](/claim/clm_A36685A1C540.md) - 2023-12-31 to 2024-12-31 | money | total_equity | 106,561,000,000 DKK | superseded | [clm_A40D8D2F280A](/claim/clm_A40D8D2F280A.md) ## 2024 - 2024-12-31 to 2025-12-31 | money | employees | 77,349 employee | superseded | [clm_6A7CC2B7840B](/claim/clm_6A7CC2B7840B.md) - 2024-12-31 to 2025-12-31 | money | net_income | 100,988,000,000 DKK | superseded | [clm_8A5C5EE097FD](/claim/clm_8A5C5EE097FD.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 128,339,000,000 DKK | superseded | [clm_109041F6F3C0](/claim/clm_109041F6F3C0.md) - 2024-12-31 to 2025-12-31 | money | revenue | 290,403,000,000 DKK | superseded | [clm_A3B9347CE850](/claim/clm_A3B9347CE850.md) - 2024-12-31 to 2025-12-31 | money | total_assets | 465,795,000,000 DKK | superseded | [clm_36763BC50C4E](/claim/clm_36763BC50C4E.md) - 2024-12-31 to 2025-12-31 | money | total_equity | 143,486,000,000 DKK | superseded | [clm_4145313CD790](/claim/clm_4145313CD790.md) ## 2025 - 2025-08-07 | people | ceo | Maziar Mike Doustdar | valid | [clm_09DBC29C37EF](/claim/clm_09DBC29C37EF.md) - 2025-12-31 | money | employees | 69,505 employee | valid | [clm_8EB909BEF688](/claim/clm_8EB909BEF688.md) - 2025-12-31 | money | net_income | 102,434,000,000 DKK | valid | [clm_F536BDE429B7](/claim/clm_F536BDE429B7.md) - 2025-12-31 | money | operating_income | 127,658,000,000 DKK | valid | [clm_672756B8F8A9](/claim/clm_672756B8F8A9.md) - 2025-12-31 | money | revenue | 309,064,000,000 DKK | valid | [clm_8F7EC31D7FFC](/claim/clm_8F7EC31D7FFC.md) - 2025-12-31 | money | total_assets | 542,902,000,000 DKK | valid | [clm_BCB17EC648AA](/claim/clm_BCB17EC648AA.md) - 2025-12-31 | money | total_equity | 194,047,000,000 DKK | valid | [clm_51EBABE50856](/claim/clm_51EBABE50856.md) ## undated - undated | people | chair | Lars Rebien Sørensen | valid | [clm_572A7A46A90E](/claim/clm_572A7A46A90E.md) - undated | other | cik | 0000353278 | valid | [clm_52A9D25B5082](/claim/clm_52A9D25B5082.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_A875D9470529](/claim/clm_A875D9470529.md) - undated | other | headquarters | Bagsvaerd Denmark | valid | [clm_71389B010ACD](/claim/clm_71389B010ACD.md) - undated | other | listed_on | OTC | valid | [clm_07286C13C782](/claim/clm_07286C13C782.md) - undated | other | listed_on | NYSE | valid | [clm_AECDFCB7C547](/claim/clm_AECDFCB7C547.md) - undated | other | registrant_name | NOVO NORDISK A S | valid | [clm_5C5C98A60302](/claim/clm_5C5C98A60302.md) - undated | other | sic_industry | Pharmaceutical Preparations (2834) | valid | [clm_52574002BF9D](/claim/clm_52574002BF9D.md) - undated | other | ticker | NONOF | valid | [clm_2B51766EA897](/claim/clm_2B51766EA897.md) - undated | other | ticker | NVO | valid | [clm_A89E46223B59](/claim/clm_A89E46223B59.md) - undated | other | website | https://www.novonordisk.com | unverified | [clm_F171E5861BC9](/claim/clm_F171E5861BC9.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.